Compound Detail
CHEMBL229257
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL229257 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AJLSSIGLWUMOCU-JXAWBTAJSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
366.9
MW (Da)
4.03
ALogP
3
HBA
2
HBD
58.2
PSA (Ų)
0.26
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 7.22
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | EC50 | 7.22 | 7.22 | 60.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | EC50 | = | 60.0 | nM | 7.22 | Enhancement of [3H]flunitrazepam binding to BZ-site of GABAA receptor in Sprague... | 17571865 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 17571865 | 10.1021/jm070083v | Unchecked | 2 |
Data from ChEMBL 36 via Core Engine